Janux Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Janux Therapeutics

10/08/2021 22:04

* Janux Therapeutics Inc  JANX.OQ  reported a quarterly adjusted
loss of 62 cents​​ per share for the quarter ended in June. The
mean expectation of two analysts for the quarter was for a loss
of 13 cents per share.
* Revenue was $482.00 thousand​;  analysts expected $200.00
thousand. 
* Janux Therapeutics Inc's reported EPS for the quarter was a
loss of 62 cents​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Janux Therapeutics Inc shares had risen by 27.1% this quarter.
* The company reported a quarterly loss of $6.21 million.
* Wall Street's median 12-month price target for Janux
Therapeutics Inc is $35.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 10 at 09:04 p.m.  ​All
figures in US dollars unless otherwise stated